The Global Type-2 Diabetes Components Market size was valued at around USD 52.7 billion in 2024 and is expected to reach USD 72.21 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.39% during the forecast period, i.e., 2025-30. According to MarkNtel Advisors Study.

Global Type-2 Diabetes Components Market Driver:

Rising Global Prevalence of Obesity and Sedentary Lifestyle – A key driver for the Global Type-2 Diabetes Market is the increasing prevalence of obesity and sedentary lifestyles worldwide. Urbanization, changing dietary habits, and reduced physical activity are leading to a surge in obesity rates, which is a major risk factor for type 2 diabetes. This trend is particularly pronounced in both developed and developing nations, contributing to a growing patient pool and heightened demand for diabetes management solutions. As more individuals are diagnosed with type 2 diabetes, the market for medications, monitoring devices, and support services continues to expand rapidly.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/global-type-2-diabetes-market.html

Key Market Reports Highlights

·        Market Dimensions & Projections

·        Pricing Evaluation

·        Recent Strategic Moves by Companies

·        Primary Stakeholders

·        Import/Export Trend Analysis

·        Competitive Landscape Assessment

·        Emerging Opportunities

·        Market Trends and Indicators

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/global-type-2-diabetes-market.html

Global Type-2 Diabetes Components Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

• By Drug Type
  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
  • Alpha-glucosidase Inhibitors
  • Biguanides
  • Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
  • Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2)
  • Sulfonylureas
  • Other (Thiazolidinediones, Meglitinides, Glitazones, etc.)
• By Gender
  • Male
  • Female
• By Age Group
  • Upto 19 years
  • 20 – 65 years
  • Above 65 years
• By Region
  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific  

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including - Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson, and others are looking forward to strengthening their market positions.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/global-type-2-diabetes-market.html

Global Type-2 Diabetes Components Industry Recent Development:

2024: Eli Lilly declared a total investment of $9 billion in its Lebanon, Indiana, manufacturing site. The site was expanded to produce APIs such as Zepbound (tirzepatide) injection and Mounjaro (tirzepatide) for the treatment of obesity and type 2 diabetes.

Data-Driven Insights Backed by Proven Research

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release - https://www.marknteladvisors.com/press-release